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Multiple sclerosis (MS) is a chronic inflammatory demyelinating disease of the central 
nervous system that affects close to 400,000 patients in the United States and roughly 2.3 
million people around the world. Because this is a growing global public health concern, 
researchers and clinicians are calling for a more efficient adoption of these McDonald 
MS guidelines in clinical practice as outlined in newly diagnosed guidelines. The purpose 
of this quantitative correlational study was to examine the relationship between the 
independent variables gender, guidelines knowledge, years in practice and intent to use 
the McDonald MS guidelines for diagnosing MS among physicians.  The diffusion of 
innovation model was used to help understand and interpret the findings. The study 
sample consisted of 161 practicing physicians who treat MS patient in the Midwestern 
United-States recruited using convenience purposeful sampling. Data were collected by 
electronic survey using Survey Monkey. Binary logistic and multiple logistic regression 
to test the association between variables yielded no association between variables or the 
presence of predictor for the outcome. Analysis revealed gender (odds ratio [OR] =1.5; 
p=.347), knowledge (OR=1.23; p= .600), and years in practice (OR=1.015; p=.404) were 
not a predictor of intent. These findings contradict research on factors affecting the 
adoption of new technologies in fields other than treatment of MS. The positive social 
change impact of understanding factors associated with the adoption of the guidelines by 
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Chapter 1: Introduction to the Study  
Multiple sclerosis (MS) is a chronic inflammatory demyelinating disease of the 
central nervous system that affects close to 400,000 patients in the United States and 
roughly 2.3 million people around the world (Tullman, 2013), which has led to a growing 
global public health concern. (World Health Organization, 2016). Guidelines exist to help 
patients with diagnosing and treatment of MS. However, researchers and clinicians are 
calling for a more efficient adoption of these guidelines in clinical practice (Harris, 
2009). The McDonald guidelines may improve disease diagnosis, predict disease 
progression, and improve clinical outcome (Harris, 2009). The topic of the study is 
physicians’ perceptions and intent to use MS McDonald guidelines for diagnosing MS. 
Appropriate use of guidelines by frontline clinicians could result in earlier detection of 
MS, reducing associated morbidity and mortality associated with the disease. Study 
findings may impact secondary and tertiary MS prevention efforts in the community. 
This chapter includes a discussion of the background, research questions (RQs), purpose 
of the study, and theoretical framework for the study. 
Background 
Physicians’ perceptions on the use of MS guidelines are hampered due to the lack 
of understanding for the etiology of MS, lack of specificity, and cost (Harris, 2009). 
However, it is necessary for clinicians to have appropriate understanding of the etiology, 
as well as a guideline that they can correctly use. This can make a difference in public 
health because as the prevalence of MS is increasing, quality of care for these patients is 




MS to be 2.3 million individuals worldwide and 400,000 in the United States (Tullman, 
2013). In the United States prevalence estimates are 90 per 100,000, and 10,000 new 
cases are diagnosed each year or 200 new cases per week (Pohlman et, al., 2010). MS can 
affect individuals between the ages of 20 and 50.  
The current diagnostic tools for MS include MRI of the brain and spinal cord, 
lumbar puncture to evaluate cerebrospinal fluid (Villoslada, 2010). But there is a need for 
clinicians to correctly use guidelines, which could provide intervention to prevent 
advanced MS disease. Guidelines that currently exist focus on myelin loss, spinal cord 
disease, gray matter, and subcortical demyelination (Villoslada, 2010). The discovery of 
innovated guidelines will depend on significant advances in proteomics and microarray 
gene and antigen analysis (Gandhi et, al.,2013). Although guidelines currently exist for 
MS, there is a need for clinicians to correctly use McDonald guidelines for diagnosing 
MS to improve community care and clinical outcomes (Martin et, al., 2006). But there is 
little research about clinicians’ level of knowledge and perceptions of the use of 
guidelines for diagnosing MS. Findings from this study will contribute to closing this gap 
in the literature. The purpose of this quantitative correlational study is to examine the 
association between physician factors and characteristics that may be associated with 
their intent to use guidelines for early diagnosis and prevention of advanced forms of MS.  
Problem Statement 
Physicians find it clinically valuable to have a measuring tool such as guidelines 
to definitively diagnose, identify reoccurrence, and treat MS (Mehr, 2015). However, 




correctly using measurable tools for accurate, early diagnosis results in poor clinical 
outcomes for the community suffering from MS (Mehr, 2015). The correct use of 
guidelines by front line clinicians is needed so that patients can be diagnosed and treated 
more effectively to prevent reoccurrences of MS related complications (Harris, 2009). 
But there is not enough research on what clinicians know about guidelines when 
diagnosing MS along with their attitudes and beliefs particularly when looking at 
physician gender, McDonald MS guideline knowledge, and years in practice. With this 
study, findings may encourage use of MS guidelines to diagnose and treat patients, which 
may lead to earlier detection and improved patient outcomes. 
Purpose 
The purpose of this quantitative correlational study was to examine the 
relationship between the independent variables gender, McDonald MS guideline 
knowledge, and years in practice, and the dependent variable of intent to use guidelines. 
The variables were analyzed with correlation, bivariate, and multivariate logistic 
regression. This study may impact MS prevention efforts by indicating factors that affect 
use of guidelines to diagnose and treat MS patients. 
Research Questions and Hypotheses 
The research questions (RQs) and accompanying null and alternative hypotheses 
for this study are: 
RQ1: What is the association between gender and the intent to use the guidelines?  





Alternative Hypothesis: There is an association between gender and intent to use 
the guidelines.  
RQ2: What is the association between guidelines knowledge and intent to use the 
guidelines.  
Null hypothesis: There is no association between guidelines knowledge and intent 
to use the guidelines.  
Alternative Hypothesis: There is an association between guidelines knowledge 
and intent to use the guidelines.  
RQ3: What is the association between years in practice and intent to use the MS 
guidelines? 
Null Hypothesis: There is no association between years in practice and intent to 
use the guidelines.  
Alternative Hypothesis: There is an association between years in practice and 
intent to use the guidelines.  
RQ4: To what extent do gender, guideline knowledge, and years in practice 
predict intent to use the guidelines? 
Null hypothesis: Gender, guidelines knowledge, and years in practice do not 
predict intent to use guidelines. 
Alternative Hypothesis: Gender, guidelines knowledge, and years in practice 




Theoretical and Conceptual Framework for the Study 
I used the Diffusion of Innovation Model to help me understand and interpret my 
findings (Rogers, 1995). This model was appropriate because it looks at the how, why, 
and at what rate technology can spread. Adoption means that a person does something 
differently than what they had previously done, and the key to adoption is that the person 
must perceive the idea, behavior, or product as new or innovative (Rogers, 1995). The 
steps in diffusion consist of knowledge, persuasion, decision, implementation, and 
confirmation. Though the diffusion of innovation model is important when evaluating 
technology acceptance and sustainability (Aizstrauta, 2014), in the context of this study, 
it takes this type of new adoption for clinicians to realize the importance of guidelines for 
MS since there is an underutilization of guidelines with MS patients. The clinical use of 
guidelines in early detection and risk assessment will recognize an important health care 
need of detecting and monitoring MS at its earliest stage. The Diffusion of Innovation 
Model helped me in my understanding of the data from the study.  
Nature of the Study 
This study was a quantitative cross-sectional correlation study in which I 
examined the association between gender, McDonald MS guideline knowledge, and years 
in practice and clinicians’ intent to the use the guidelines. This methodology was 
appropriate for the study because it allowed me to quantify the association between the 
variables. Independent variables in the study were gender, McDonald MS guideline 
knowledge, years in practice, and the dependent variables was intent to use the 




161 practicing physicians from the Midwest who are in private practice or practicing at 
major medical centers.  
Definitions 
The following section includes a list of key constructs and their definitions.  
Multiple sclerosis (MS): Demyelinating and chronic disease of the central nervous 
system in which the insulating covers of nerve cells in the brain and spinal cord are 
damaged. This construct will measure how well biomarkers detect MS (Loma, 2011). 
Gender: Biological designation of male or female (Miguez, 2014). 
Guideline’s knowledge: Knowledge is the level of understanding and knowledge 
about the McDonald MS guidelines (Guo, 2014). 
Assumptions 
The first assumption was that physicians’ knowledge about McDonald MS 
guidelines may be varied.  The second assumption was that guideline clinical use may be 
varied, and clinicians responded truthfully to the questions on the survey. The advantages 
are these more robust guidelines are clinically useful for clinicians to make a proper 
diagnosis and treatment plan for the patients (Housley et, al., 2015). 
Scope and Delimitations 
The scope of the study focused on the selected physician characteristics gender, 
McDonald guideline knowledge, and years and practice and the dependent variable intent 
to use. I explored intent to use the McDonald guidelines only, not their actual use. The 
populations included in the study include physicians who diagnose and treat MS patients 





The limitations of this cross-sectional correlational methodology are that it is not 
used to analyze behavior or establish cause and effect. The limitations to external validity 
consisted of population and ecological validity.  Another limitation is recall bias as this is 
a main drawback to surveys.  
Significance 
      Although McDonald MS guidelines may exist for MS there is a need for clinicians to 
correctly use of guidelines for diagnosing MS to improve community care (Martin et, al., 
2006). But there is little research about clinicians’ level of knowledge and perceptions of 
the use of guidelines for diagnosing MS. The public health concern for MS in the 
community is the growing prevalence, disability, and cost of MS; with better use of 
guidelines this burden could be reduced. Addressing clinicians’ perceptions can improve 
their quality of care, cost, and access within the healthcare system. The appropriate use of 
McDonald MS guidelines by frontline clinicians could result in earlier detection and 
more effective treatment of MS thus reducing associated morbidity and mortality. 
Summary 
The prevalence of MS is growing including the diagnosis of MS. The purpose of 
this quantitative correlational study was to examine the association between physician 
characteristics that may be associated with their intent to use the McDonald guidelines 
for early diagnosis and prevention of advanced forms of MS. It is important to examine 
the association between physician factors and clinical factors like gender, McDonald MS 




understand their implementation or lack of implementation in practice. Increased and 
consistent use of the McDonald MS guidelines could result in earlier detection and more 
effective treatment of MS thus reducing associated morbidity and mortality associated 
with the disease. Roger’s Diffusion of Innovation Model was used to help me understand 
and interpret my findings (Rogers, 1995). Data for this study were collected through an 
electronic survey that was emailed to practicing clinicians from across the Midwest and 
at major academic institutions.  Chapter 2 includes a detailed literature review on MS and 









Chapter 2: Literature Review 
The implementation of guidelines by front line clinicians is needed so that 
patients can be diagnosed and treated more effectively to improve patient outcomes and 
establish more valid diagnostic tests and immunotherapies (Harris, 2009). For instance, 
the McDonald MS guidelines can be used to definitively diagnose, identify reoccurrence, 
and treat MS (Mehr, 2015). However, there is a need for a more efficient adoption of 
these guidelines (Harris, 2009). It has been challenging to establish an effective guideline 
because of the clinical and pathophysiological complexities of the disease (Katsavos et, 
al., 2013). This understanding of which mechanism is most relevant is challenging in 
deciding which is the appropriate therapeutically immunotherapy choice.  
At present, the clinical application of neutralizing antibodies interferon beta as a 
guideline is what clinicians are using to treat MS even though it lacks specificity and 
sensitivity, and with current validation studies that are currently occurring, cerebral spinal 
fluid (CSF) analysis of fetuin-A and other markers, such as ostepontin could be routinely 
used and a more effective option (Harris, 2014). The current study discussed possible 
guidelines that are relevant and include HLA-DRB1, polymorphisms, oligoclonal bands, 
vitamin D, TOB-1, ApopE. S100B and conventional and nonconventional imaging 
techniques to name a few (Katsavos et, al., 2013). But without an effective guideline it is 
difficult to personalize the treatment with an effective immunotherapy. The clinical 
management of patients with MS can improve with a reliable biomarker and improve 




chapter includes the literature search strategy and a comprehensive review of the relevant 
literature on MS and the McDonald guidelines.  
Literature Search Strategy 
The databases used included the library resources at the Washington University 
School of Medicine in St. Louis, St. Louis University School of Medicine, Lindenwood 
University in St. Louis, and search engines included EBSCO host, google scholar. The 
key search terms included were MS and guidelines, current research and development 
with MS guidelines, current challenges or limitations of MS guidelines, and clinical 
factors associated with clinician’s intent to use the guidelines. The years searched 
included 2015-2020 for data and peer reviewed articles. 
Theoretical Framework 
I used the Diffusion of Innovation Model to help me understand and interpret my 
findings (Rogers, 1995). This diffusion of innovation model is used to evaluate 
technology acceptance and sustainability (Aizstrauta, 2014), determining the how and 
why technology spreads. This model is appropriate for my study because it takes this type 
of new adoption for clinicians to realize the importance of guidelines for MS.  
Literature Review 
Epidemiology of MS 
MS is an acquired inflammatory and neurodegenerative immuno-mediated 
disorder of the central nervous system, and its distinguishing features consist of 
inflammation, demyelination, and primary and secondary axonal degeneration (Pugliatti 




limb weakness, gait problems, and bladder and bowel symptoms that often accompany 
irreversible functional disability over time (Puglatti et, al., 2006).  
MS affects 400,000 people in the United States and 2.5 million people worldwide 
(Puglatti et, al., 2006). The prevalence estimates are 90 per 100,000 population and MS 
symptom age can start anywhere from 20-50 to 80 years old, but mean age is 32 
(Williamson, 2009). The lowest prevalence has been in the Texas area, intermediate in 
the Missouri area, and highest in the Ohio area (Williamson, 2009). The United States 
MS prevalence is highest among women, aged 40 to 59 years old and non-Hispanics, and 
approximately 85% of affected people have a relapsing-remitting course, and an unsteady 
course of exacerbations and remissions (Williamson, 2009). The latitude increase 
gradient in MS incidence over the last 25 years tied to regions closer to the equator, and 
an increase in the female to male ratio among MS cases (Alonso, 2008). Europe is 
considered a higher region for MS with 30,000 per 100,000 and higher prevalence and 
incidence tended to be higher in the Northern regions of the United Kingdom and in the 
Nordic countries, suggesting the importance of the role of latitude (Kingwell et, al., 
2013). In Europe, the MS incidence is 4.3 cases per 100,000 and the total prevalence in 
Europe the past three decades is 83 per 100,000 and higher rates in northern country and 
a female to male ratio around 2.0 (Pugliatti et, al., 2006).  
Some of the proposed causes of MS include genetics, smoking, and reproductive 
factors (Alonso, 2008; Poorolajal et, al., 2017) The literature has also demonstrated that 
the incidence of MS in influenced by numerous factors, including patient gender, age, 




infectious diseases, pregnancy, and assisted reproduction (Kalincik, 2015). Additional 
factors that influence MS incidence include population genetics, the interplay between 
genes and a geographically determined physical environment, socioeconomic structure 
including the availability of medical facilities (Tullman, 2013). Additional research 
shows that besides the established MS associated risk factors insufficient sun exposure, 
dietary intake, Epstein-Barr virus infection, and obesity during adolescence all play an 
important role and can lead to more cases of MS (Olsson et, al., 2017). In addition, 
personality has been considered a difference in overall health and well-being, and those 
individuals with a type D or distressed personality with MS tend to have poorer outcomes 
(Strober, 2016). However, early-stage MS patients who had adequate levels of vitamin D 
had a 57% lower rate of new brain lesions, a 57% lower relapse rate, and a 25% lower 
yearly increase in lesion volume than those with lower levels of vitamin D (Harvard 
School of Public Health, 2016). 
Public Health Impact of MS  
There is significant evidence that MS as a neurological disorder poses a great 
threat to public health. MS disease characteristics significantly affect dimensions of 
quality of life (Rezapour et, al., 2017). Major depression prevalence in those diagnosed 
with MS in the 18 to 45-year-old range was high at 25.7% (Patten et, al., 2003). Not only 
can depression be a public health concern for these MS patients, but there may be a 
greater risk of harm to the MS patients due to substance abuse including alcohol and 
illicit drug use in people with MS because of the possible magnification of motor and 




MS Prevention History and Current State of the Science 
As stated, MS can be caused by strong environmental factors that include vitamin 
D status, infection with Epstein Barr virus, and cigarette smoking (Ascherio, 2008). More 
importantly genetic factors play a significant factor as well as the strongest risk factor for 
MS is family history (Ascherio, 2008). The keys to MS prevention with these genetic risk 
factors are the systemic screening of the whole genome. A large international consortium 
has been established to identify the genetic determinants of MS as the HLA-DRB1 locus 
has been linked along with additional loci to an MS risk (Asherio, 2008). Other 
prevention methods for environmental causes of MS include moving to area of lower 
latitudes because of the importance of the correlation of vitamin deficiency at higher 
latitudes and MS incidence. (Asherio, 2008). Vitamin D effectively reduces the risk of 
MS; thus, it is important to provide supplementation in adolescents and young adults. 
Because of the correlation of smoking to MS, if smoking was eliminated, up to 6% of the 
MS cases could be prevented (Asherio, 2008). Further, to prevent MS from further 
progressing in diagnosed individuals, there are many recommended therapies (McNamara 
et, al., 2017). However, MS is progressive disease with no cure, therefore MS may 
worsen in some patients despite everything the patient and physician do (Murray, 2006). 
MS Diagnostic History and Current State 
MS diagnostic history in the 1980’s relied on the evidence of at least two relapses 
typical of MS and evidence of white matter in more than one site in the central nervous 
system (Murray, 2006). New research has shown new criteria known as McDonald 




demonstrate multiple areas of involvement and involvement over time (Murray, 2006). 
These McDonald criteria also include the Barkhof-Tintore MRI criteria, which include 
three of the four elements and at least one gadolinium enhancing lesion or 9 T2 
hyperdense lesions, at least one infratentorial lesion, at least one juxtacortical lesion, and 
at least 3 periventricular lesions, and a spinal cord lesion can substitute any of the above 
brain lesions (Inglese, 2006) The current diagnostic criteria for MS are based on lesions 
within the central nervous system that demonstrate dissemination in space and time 
(Rovira, et, al., 2015). The high sensitivity of the MRI in the depiction of plaques in the 
brain and spinal cord has made this technique valuable for diagnosing MS (Rovira et, al., 
2015). In addition, an MS diagnosis is dependent on a detailed medical history, careful 
neurological examination, and additional paraclinical investigations such as MRI imaging 
scans, CSF, evoked potentials, and blood tests (Inglese, 2006). The implementation of 
MRI imaging reveals multifocal white cerebral white matter lesions in more than 95% of 
patients and in 75-85% of these are focal spinal lesions (Inglese, 2006). However, no 
single test including a tissue biopsy can provide a definite diagnosis of MS. The past few 
years have seen improvement in the development of laboratory and imaging approaches 
to the diagnosis of MS, but the use of diagnostic guidelines is important as well.  
Lack of Correct and Consistent Use of McDonald Guidelines 
One of the biggest challenges for clinicians is that the disease prognosis and 
individual therapeutic outcomes can be difficult to predict with MS (Harris, 2014), 





Some of the clinical parameters that physicians use depends on MS relapse rates, 
MRI outcomes, and various changes in disability scores (Harris, 2009). Thus, there is an 
unmet need for more sensitive and specific MS guidelines to better effectively diagnose 
and treat MS. With more consistent and accurate guidelines, the clinicians will have an 
accurate measurable tool that is better able to better assess and predict medical therapy 
outcomes (Harris, 2009).  
Despite the need for consistent guidelines, research on the etiology of MS is still 
ongoing because it is difficult to confirm the exact etiology or cause of MS along with 
understanding of the mechanism that is driving the disease (Harris, 2009). But MCAM 
(melanoma cell adhesion molecules) are a potential diagnostic guideline for MS, as the 
data show that the expression of the molecule on T cells correlates with MS disease 
activity (Muccilli, et, al., 2017). The strength in this approach is that researchers are 
looking for additional correlations across various disease states including a correlation to 
melanoma in trying to identify a new diagnostic guideline. The weakness in this approach 
is whether the peripheral expression of melanoma cell adhesion molecules can also 
predict MS relapses.   
Additionally, “NMO-IgG antibodies became the first clinically useful diagnostic 
guideline that looked at a subgroup of patients with classic MS” (Comabella, 2014). All 
molecular guidelines used at present in MS clinical practice are the proteins, and those 
that measure humoral immune response are easier to integrate into clinical practice 
(Comabella, 2014).  Further, CSF is one of the most informative body fluids in which to 




However, the CSF is obtained by an invasive procedure that restricts repeated collection 
and can make it challenging in clinical practice.  
Thus, the use of diagnostic guidelines detected in other body fluids such as IgG 
oligoclonal bands in tears may warrant further investigation for better application in 
clinical practice (Comabella, 2014). The ideal test to appropriately measure a guideline 
should have solid analytical and clinical precision and should be clinically useful to 
improve patient outcomes.  
Infectious agents have also been suggested to have a role in terms of 
environmental factors in MS. This includes the gastrointestinal commensal bacteria 
having been implicated in the pathogenesis of autoimmune diseases like MS. Identifying 
a unique gastrointestinal and oral bacteria derived lipedipeptide, Lipid 654, which is 
produced by commensal bacteria and functions as a human and mouse like Toll-like 
receptor 2 ligand, may help in the diagnosis of MS (Farrohki, et, al., 2013). Lipid 654 is 
expressed at significantly lower levels in the serum of patients with MS compared to 
healthy individuals (Farrohki, et, al., 2013). But there is still no clear pathogenesis of MS 
as several theories exist out there regarding the exact cause and mechanism of the disease 
(Farrohki et, al., 2013). 
Peer-reviewed evidence also validates clinicians’ use of McDonald MS guidelines 
because of its effectiveness for diagnosing MS, across other therapeutic areas that have 
the same type of mechanism as MS. Clinicians should implement this measure tool 
because there is an immediate need to improve patient outcome and personalized 




clinicians with an intent to use a specific guideline and thus guide their therapeutic 
treatment.  
Other important peer- reviewed articles show that a biomarker blood test can 
determine the type of MS someone has with an accuracy of 85 to 90 %, and thus improve 
patient outcome by allowing clinicians to adapt to treatments faster (Farrohki et, al., 
2013). A potential guideline that involves tryptophan in which researchers look at the 
importance of that being known to be involved in brain inflammation. A reliable 
guideline will guide personalized treatment for each patient, which will improve patient 
outcomes. However, further research is still needed on this diagnostic guideline, as there 
are other diseases associated with inflammation and neurodegeneration besides MS and 
that includes Alzheimer’s, Parkinson’s, and Lou Gehrig’s disease (Farrohki, et, al., 2013). 
Separating MS from other neurodegeneration and inflammatory conditions with 
this guideline and trying to separate from Alzheimer’s or Parkinson’s disease can be 
challenging considering the various disease states that have inflammatory conditions, so 
there is a need for a precise guideline. 
Studies show that using high throughput body profiling by MALDI-TOF mass 
spectrometry, small proteins and peptides have been detected as promising candidate 
guidelines for disease diagnosis and disease progression of MS (Teunissen et, al., 2011). 
The strength of this study is the potential for promising clinical biomarkers for clinicians 
to adapt to, and the weakness with this is still investigating MALDI-TOF mass 
spectrometry and how this plays a significant role in MS guidelines. The rationale for this 




potential new candidates for MS disease diagnosis like mass spectrometry that have not 
existed before.  The correlation with this study is clinical factors that are produced from 
electric and magnetic fields and a clinician’s intent to use a guideline (Teunissen, et, al., 
2011). 
These research studies support this because it discusses the importance of the 
development of these process specific therapies which will be impossible without the use 
of guidelines that reflect the targeted process and how this target process can aid in the 
more rapid screening of therapeutic agents as well (Bielekova, 2004). This is crucial 
because having this process-specific guideline is a reason why it cannot serve as a 
surrogate for a clinical outcome because of the complexity of MS (Bielekova, 2004). The 
strength of this study is that with more of a targeted approach it will help the therapeutic 
approach and aid in a more rapid screening process and in the development of therapeutic 
agents. The weakness in this approach is that there is a high degree of complexity of 
understanding MS because of the complexity of the disease and the difficulty of finding a 
single guideline (Bielekova, 2004). 
The rationale for this approach is a clinician’s intent to use a  McDonald MS 
guideline by understanding this as a measurable tool that has a great ability to be targeted 
specifically for MS patients since challenges do exist that are being presented by being 
such a complex disease. The correlations are important that are presented in this study 
because the importance of identifying clinical factors through an effective screening 
process is important in MS along with the development of immunotherapy agents. The 




disease will be difficult to identify a single guideline to improve clinical outcome 
(Bielekova, 2004). 
The findings from the following studies demonstrate an important point because 
this study shows significant changed expression of selected extracellular miRNA in 
plasma of MS patients. This is important because these observations may help suggest 
that miRNA subsets may be potential guidelines for MS activity (Kacperska, et, al., 
2015). The strengths of this study are that even though an ideal guideline of MS has still 
not been found, the strength is that a group of endogenous, single-stranded noncoding 
RNA molecules shows promise (Kacperska, et, al., 2015). With a better understanding of 
microRNA profiles in each disease may aid in a quicker and accurate diagnosis while 
also having universal prognostic factors. The weaknesses of this study are that the use of 
miRNA expression differs depending on a stage of MS whether it is relapse vs remission.  
The rationale for this approach is significant because these miRNA molecules 
could aid in a quicker and accurate diagnosis (Kacperska et, al., 2015). This is important 
because a quicker and accurate diagnosis will improve patient outcome for MS patients. 
The correlation in this study is important because looking at clinical factors such as 
microRNA profiles of patients provides physicians with an intent to use guidelines and 
effective immunotherapy treatments. The controversy with this study is that more 
research needs to be done in this area especially in turn how useful in clinical practice 
these new guidelines could really be effective. 
The study supports the significance of this because it discusses the 




picture of MS, which in turn will help with therapeutic strategies. The strengths of this 
study are that it provides another perspective at looking at identifying guidelines and 
provides a complete picture of MS, especially our understanding of acute lesion 
pathophysiology and its noninvasive follow-up. This is relevant because this approach 
will provide in vivo sensitive and specific look at MS components to improve the 
diagnostic performance, the pathophysiology, and our ability to follow the course of this 
disease when looking at the future of therapeutic development and monitoring (Tourdias, 
2013). The weakness of this study is the complex cascade of events that could take place 
with acute inflammatory lesions like cell recruitment and edema formation. There can be 
an issue with this because there are other guidelines of consequences of acute 
inflammation like matrix digestion by metalloproteinase, acute demyelination, and axonal 
injury (Tourdias, 2013). 
The rationale for this study is that it provides another angle at looking at potential 
guidelines for MS, especially from an imaging perspective. These MRI and positron 
emission tomography markers of neuroinflammation will be a valid approach to assess 
the neurodegeneration component of MS, particularly the axonal loss and incomplete 
remyelination (Tourdias, 2013). The correlation is important in this study because clinical 
factors of inflammation provide clinicians with an intent to use a guideline and effective 
immunotherapy. “The controversy around this study is that there are other markers of 
inflammation that need to be considered here, so the research is still ongoing in 





Further research validates that these proteins semaphorin 7A and ala-B-
dipeptidase can play an important role as CSF biomarkers (Canto, et, al., 2014). The 
strengths of this study are that it provides some validation of specific proteins as 
biomarkers while using different techniques in individual CSF samples. The weakness is 
that in this study there were other proposed proteins as candidates for guidelines were not 
validated in the individual CSF samples.  
The rationale for this study is to look at how different proteins play a role in 
guidelines, and which ones are more specific than others in determining an appropriate 
guideline candidate for MS (Canto, et, al., 2014). The correlation is relevant because of 
the clinical factors of particular proteins that patients may exhibit and a clinician’s intent 
to use a guideline and effective immunotherapy. The controversy with this study is trying 
to identify which proteins are more valid than others as the study has identified 
appropriate candidates and not valid candidates for potential guidelines. 
Additional studies are crucial because additional studies discuss the glial 
potassium channel KIR4.1 as potential guideline. According to the research antibodies 
against KIR4.1 were observed in 46.9% of patients with MS, but were essentially absent 
in people with other neurological diseases and healthy donors (Wunsch et, al., 2014). The 
strengths of this study are significant because the impact of immune responses against 
antigens of gastric parietal cells on the KIR4.1 reactive antibody in patients with MS is 
clinically significant (Wunsch et, al., 2014). The weakness of this study is that in the data 




antibody in the CSF so there still needs to further clarity on the research (Wunsch et, al., 
2014). 
The rationale for this study is that KIR4.1 antibody could play an important role 
in identifying new guidelines for clinicians. The correlation in this study is clinical 
factors associated with KIR4.1 antibody are an important because this provides validation 
for clinician’s intent to use a guideline when patients have these KIR4.1 antibody. The 
controversy with this study is the clarity that needs to be confirmed regarding KIR4.1 
antibody as research is still ongoing regarding showing resulting pathological effects in 
the CNS and gut (Wunsch et, al., 2014). 
Additional study is important because it looks at the activation of the kynurenine 
pathway of tryptophan metabolism results from chronic inflammation like MS. Also, the 
kynurenine pathway of the tryptophan metabolism is highly inducible in inflammatory 
environments, and that changes in KP may be associated with MS (Kim, et, al., 2017). 
The strength of this study is that researchers are constantly considering biochemical 
pathways that are causing MS like the KP pathway. Also, the conclusions of the study 
show a strong association with KP parameters and MS subtype. The weakness associated 
with this study is this study only looked at tryptophan and unfortunately was not capable 
of looking at downstream KP metabolites (Kim et, al., 2017). 
The rationale for this study is that additional biochemical pathways exist in 
looking at identification of MS guidelines and further validates this as a viable option as a 
guideline. The correlation with this study is important because this shows clinical factors 




clinician’s intent to use guidelines. The controversy with this study is that it did not look 
at other downstream KP metabolites (Kim et, al., 2017). 
Furthermore, additional articles show that 40% of MS cases studied it shows 
detectable alpha-GA1C reactivity, which is potentially indicative of a particular type of 
MS in terms of disease course and severity (Menge et, al., 2005). The strength of this 
study is that mechanisms have been postulated with galactocerebroside and how this can 
be implemented in the near future. The weakness of this study is that pathophysiological 
explanation for the delayed response is not known. The rationale for this study is 
exploring additional novel findings which demonstrate guideline capability for MS 
diagnosis, staging, and prognosis (Menge et, al., 2005). The correlation that is important 
in this study is clinical factors such as patients having these enzyme disruptions with 
galactocerebroside and a clinician’s intent to use guidelines and immunotherapy. The 
controversy with this study is the need for clarity around the pathophysiological 
explanation with MS. 
The importance of this study demonstrates that immunophenotyping of CSF cells 
in MS is becoming more important to correlate cellular subsets with different disease 
activity and remission (Alvermann et, al., 2014). The strength of this study is that 
characterization of CSF cells allows researchers to understand MS pathogenesis and to 
provide appropriate guidelines, individual prognosis, and treatment decisions (Alvermann 
et, al., 2014). The weakness of this study is that other leukocyte populations including 
natural kills cells, monocytes, and dendritic cells show variation as well (Alvermann et, 




use guidelines. The correlation with this study is how these CSF clinical factors can play 
a role in clinician’s intent to use guidelines and immunotherapy. The controversy with 
this study is that several other leukocyte populations need to be further examined. 
The next study shows that lipid dysregulation plays a role in MS progression of 
disability. The strength of this study is the identification of novel cholesterol subsets and 
plasma triglycerides in MS patients including the use of the treatment of simvastatin 
(Alvermann et, al., 2014). The weakness of this study is that these results were 
independent of age and sex. The rationale for this study is to demonstrate the importance 
that lipid dysregulation plays with people with MS as it pertains to progression and 
disability. The correlation is important because clinical factors like lipid dysregulation 
plays a role in clinician’s intent to identify a guideline. The controversy with this study is 
that these results are independent of age and sex, and also could discriminate disease state 
with high specificity and sensitivity (McKechnie, 2017). 
Additional studies are important to address because this states that a useful 
guideline in MS would allow for early identification of MS patient subsets and guide 
their personalized treatment plan. The study discusses that the only robust guidelines 
utilized in current practice are the MRI and CSF oligoclonal bands, but both which 
provide limited prognostic information (Butterworth et, al., 2015). The strengths of this 
study are that the study succeeded in showing a gene SLC9A9 associated with treatment 
response. “The study discusses altered gene expression could lead to altered 
glycosylation, an important mechanism regulation inflammation, implicating gene 




activity” (Butterworth et, al., 2015). The weaknesses in this study are that some plasma 
levels in MS have not demonstrated sufficient specificity and sensitivity to be a viable 
guideline.  
The rationale for this study is that it shows that robust guidelines solutions do 
exist but do not provide enough information to create the most efficient prognostic 
measurable tool (Butterworth et, al., 2015). This study discussed other options including 
gene expression which can play an important role in the inflammatory process and MS. 
The correlation in this study is that patients that exhibit gene expression led to clinician’s 
intent to use guidelines for future immunotherapies. The controversy within this study is 
the challenge to develop a guideline with efficient prognostic solutions since robust 
guideline exist, but not enough to produce prognostic information that clinicians are 
expecting.  
After an extensive search of the literature, I did not find other studies that used 
gender, years in practice or knowledge about a targeted content to predict intent. 
However, there are other recent studies that examine gender as a predictor for an 
outcome. Wlodarczyk (2020) examined gender and predictors of post-MI HRQoL 
(health-related quality of life) and found a difference between female and male survivors 
of a myocardial infarction (Wlodarczyk, 2020) Additional studies focused on gender 
included patient gender differences in the prediction of medical expenditures (Bertakis, 





Review of the Proposed Methodology 
The research design for the proposed study was a quantitative correlation study to 
examine the relationship between the independent variables including gender, McDonald 
MS guideline knowledge, and years in practice, and the dependent variable intent to use 
the guidelines.  
Lynd (2014) used correlation and regression analysis first study looked at 
quantitative analysis of MS patients’ preferences for drug treatment as the objective was 
to elicit patients’ preferences for different attributes of MS drug therapy (Lynd et, al., 
2014). The second study looked at a comparative quantitative study of axonal injury in 
active, inactive, and remyelinated lesions with MS. The objective of this study discussed 
the importance of magnetic resonance studies of MS lesions indicate that axonal injury is 
a major correlate of permanent clinical deficit (Kornek et, al., 2000). The third study is a 
quantitative study of water diffusion in MS lesions and normal appearing white matter 
using Echo-Planar imaging. “The objective of this study shows that diffusion-weighted 
imaging is able to identify MS lesions with severe tissue disruption” (Flippi et, al., 2000). 
These additional citations and references demonstrated the quantitative methodology is 
sound and has been used by other researchers. Specific to my proposed analysis method 
of binary logistic regression several studies have been found in the literature. Boamah 
analyzed predicting social trust with give demographic variables from a national sample 
of individuals who participated in the General Social Survey (GSS). (Boamah, 2015). 
Schober (2021) analyzed the association between the induction technique and the risk of 




examined binary logistic regression instrument for assessing museum indoor air impact 
on exhibits (Bucor, 2017).  
Summary and Conclusions 
The major themes in the study include the role of epidemiology of guidelines in 
MS, the public health impact of MS, MS prevention history and current state, the MS 
diagnostic history and current state, and finally the lack of correct and consistent use of 
guidelines along with additional studies with my proposed methodology. I addressed the 
importance of how prevalent MS is and the need for clinicians to use an effective 
guideline to not only help MS patients but also the field of public health. The 
development and use by clinicians’ of effective McDonald MS guidelines, the public 
health field can be positively impacted because effective guideline use this will lead 
toward more personalized and targeted care for these patients in order to improve patient 
outcome. The study highlighted a call from the profession to use the MS guidelines in 
clinical practice. There is a clinical need for not only MS, but also across other 
therapeutic inflammatory areas that have the same type of mechanism. Furthermore, with 
this study it provides clinicians another opportunity to use guidelines considering 
potential new candidates for MS disease diagnosis like mass spectrometry that have not 
existed before.  Another major theme in this study is that it provides another perspective 
at looking at potential guidelines for MS, especially from an imaging perspective. These 
MRI and position-emission tomography markers of neuroinflammation will be an 
excellent approach to assess the neurodegeneration component of MS, particularly the 




because clinical factors of inflammation provide clinicians with an intent to use 
guidelines and effective immunotherapy. Finally, the importance of having a sustainable 
measurable MS guideline is critical in the field of medicine and public health as patient 
outcome will improve along with improvement on the economic burden of patients in 
society. An effective MS guideline tool provides a solution for clinicians to effectively 
diagnose, monitor, and treat MS patients with more accuracy and precision to improve 
patient outcome.  In Chapter 3, I discuss the research design and rationale, methodology, 






Chapter 3: Research Method 
The purpose of this quantitative study was to explore the relationship between 
selected physician characteristics including gender, McDonald MS guideline knowledge, 
and years in practice and intent to use the new guidelines for diagnosing MS. I collected 
data with a survey administered by email to practicing physicians from across the 
Midwest. The study addressed what physician characteristics might be associated with 
intent to use McDonald MS guidelines for the diagnosis, monitoring, prevention, and 
treatment of MS. The major sections of this chapter include a description of the research 
design and rationale, methodology, threats to validity, and summary. 
Research Design and Rationale 
This was a quantitative study with bivariate and regression analysis. The 
independent variables included gender, McDonald MS guidelines knowledge, and years 
in practice, and the dependent variable was intent to use the guidelines for the diagnosis 
and prevention of MS. A quantitative research design was appropriate given the nature of 
the RQs. The time and resource constraints consisted of waiting for the return of the 
survey data from the physicians with their busy schedules seeing patients. A detailed and 
specific follow up reminder email was provided to the physicians to encourage them to 
take and return the survey. In addition, I emailed reminders every week throughout the 
duration of the data collection phase of the research project.  
Research Questions and Hypotheses 




RQ1: What is the association between gender and the intent to use the guidelines? 
Null Hypothesis: There is no association between gender and intent to use the guidelines.  
Alternative Hypothesis: There is an association between gender and intent to use 
the guidelines.  
RQ2: Research question: What is the association between guidelines knowledge 
and intent to use the guidelines? 
Null hypothesis: There is no association between guidelines knowledge and intent 
to use the guidelines.  
Alternative Hypothesis: There is an association between guidelines knowledge 
and intent to use the guidelines.  
RQ3: Research question: What is the association between years in practice and 
intent to use the MS guidelines? 
Null Hypothesis: There is no association between years in practice and intent to 
use the guidelines.  
RQ4: To what extent do gender, guideline knowledge, and years in practice 
predict intent to use the guidelines? 
Null hypothesis: Gender, guidelines knowledge, and years in practice do not 
predict intent to use guidelines. 
Alternative Hypothesis: Gender, guidelines knowledge, and years in practice do 






The target population was practicing physicians (neurologists and primary care 
physicians) in the Midwest who diagnose and treat MS patients. The study population 
was practicing MD and D.O physicians who were either in private or hospital-based 
practice.   
Sampling and Sampling Procedures 
The study population consisted of MD and D.O. physicians across several states 
(Missouri, Illinois, Kansas, Oklahoma, Iowa, Arkansas, Nebraska) in the Midwest who 
treat MS patients. Convenience sampling was used because of constraints of time and 
other resources. I chose to purposefully sample physicians residing in states near where I 
live in Missouri.  The study participants were identified with an online search of all 
neurologists and primary care physicians in network who treat MS patients within the 
Midwest. Potential participants were invited via email to participate in the study.  Those 
who agreed were asked to take a survey using Survey Monkey. Physicians who do not 
treat these types of MS patients or who currently use the guidelines were excluded from 
the study. 
Procedures for Recruitment, Participation, and Data Collection 
Recruitment Procedures 
The steps for recruitment included emailing invitations to the physicians to 
participate in the study. I determined eligibility, ensuring that that the participants treat 




population. This included both the neurologists and primary care physicians holding an 
M.D. or D.O degree and license to practice medicine in their state. I screened potential 
candidates using a short screening questionnaire when they accessed Survey Monkey. I 
then provided access to a previously developed self-administered survey on Survey 
Monkey. The participants provided informed consent acknowledgement on the first page 
before they took the survey to ensure that privacy and informed consent was respected.  
For collecting data, I implemented response validation in which I made sure respondents 
submitted their answers in the right format. Follow up procedures included my contact 
information and email had any of these physicians wanted to contact me for a follow up 
interview, live visit, or phone call. 
Minimum Sample Size Calculation 
I calculated the minimum sample size needed for this study using the G Power 
calculator for sample size computation for binary logistic regression (Faul, et 
al.,2009). This calculation was based on one dichotomous independent variable, gender 
(male/female) and the dichotomous outcome, intend to use or do not intend to use the 
McDonald guidelines for diagnosing MS.  Because of the lack of published research on 
the use of the McDonald guidelines, and based on my personal experiences working with 
physicians who treat MS, I hypothesized that male physicians were more likely to state 
intent to use the guidelines than women physicians. However, the final gender 
distribution of the sample consisted of 47% male physicians and 53 % female 
physicians.   Thus, assumptions were made that 50% of male physicians and 30% of 




determined that a minimum sample size of 312 respondents would be needed for the 
analysis for an odds ratio (OR) of 2.3, and 95% power (see Figure 1). I attempted to 
recruit at least 500 respondents to increase the power of the study. However, despite 
several attempts to recruit more potential participants, I was not able to achieve the 500 




G Power Output for Sample Size Calculation for Binary Logistic Regression, 
Dichotomous Independent, and Dependent Variable 
Options:       Large sample z-Test, Demidenko (2007) with var corr 
Analysis:      A priori: Compute required sample size 
Input:            Tail(s)                                               =   Two 
                       Odds ratio                                        =   2.3333333 
                       Pr(Y=1|X=1) H0                              =   0.3 
                       α err prob                                        =   0.05 
                       Power (1-β err prob)                       =   0.95 
                       R² other X                                        =   0 
                       X distribution                                  =   Binomial 
                       X parm π                                         =   0.47 
Output:         Critical z                                          =   1.9599640 
                       Total sample size                            =   312 
                       Actual power                                   =   0.9500790  
 
Procedures for Informed Consent 
The informed consent process involved giving adequate information concerning 
the study, providing sufficient opportunities for the participants to consider all options, 
responding to the subject’s questions ensuring that the subject had comprehended this 
information while obtaining the participants voluntary agreement. For informed consent, 
a drafted word document with a voluntary agreement for physicians to participate in this 




consent was provided in written format, sent by email to each participant who indicated a 
willingness to participate. The physicians understood the research and the risks involved 
within a written consent.  If reading the informed consent document and they have 
questions, they would respond to questions by email within 48 hours of receipt. There 
will be immediate follow up to the physician if there are any missing data. The survey 
was non-anonymous and confidential was guaranteed with informed consent. This was 
designed to capture any reported changes or final questions that the physicians may have, 
and physicians were able to contact me directly via email or phone. No physicians 
contacted me regarding follow up. Also, the study was approved by the Walden (IRB # 
01-21-20-0311462). 
Data Collection 
Data was collected in writing via an electronic survey accessed by participants 
online using the Survey Monkey software. Data was collected from March 2020-August 
2020. The survey had five parts including:  the screening tool for eligibility, the informed 
consent form, the demographic data form, the main survey questions, and closing 
paragraph and form (see Appendix A). The sampling frame included all the physicians 
with an MD or DO degree and license to practice medicine in their state in community 
practice which included neurologists and primary care physicians who treat MS patients 
in the Midwest.  
Consensus Validity for the Survey 
To increase the internal validity of the survey that I developed, I consulted with a 




for accuracy and construct validity to achieve consensus validity.  The names and contact 
information of the panelist were provided to my committee chair for review and approval. 
Results of the review were made available to my committee members. The panelists 
provided encouraging feedback that the survey being used was accurate with the study.  
Pilot Study 
I conducted a small pilot study prior to implementing the main study. I selected 
three physicians similar to the physicians in my main study in order to test my sampling 
strategy, the ease and logic of taking the survey-on Survey Monkey, and completeness 
and clarity of my survey data collection instrument. I first received approval from the 
IRB before conducting the pilot study.  As a result of the pilot study and encouraging 
feedback from the three physicians I proceeded to the next steps. I did not do any analysis 
of data with the pilot study. Overall, I received positive comments from the three 
physicians regarding the sample strategy feedback, ease and logic of taking survey, and 
completeness and clarity of my survey data collection instrument. 
Data Analysis 
Since my outcome of interest is physicians’ perceptions and intent to use 
McDonald MS guidelines for diagnosing MS, I used binary logistic regression for the 
bivariate analysis. 
The software used for the analysis was SPSS version 27. My data preparation and 
cleaning plan included checking and dealing with missing data, linearity, outliers, 
multicollinearity, and homoscedasticity. The primary RQs for this study were:  RQ1: 




is the association between McDonald MS guideline knowledge and intent to use the 
guidelines? RQ3: What is the association between years in practice and intent to use the 
MS guidelines? RQ4: To what extent do gender, guidelines knowledge, and years in 
practice predict intent to use the guidelines? 
The analysis plan included a descriptive analytical component consisting of the 
use of percentages distributions and measures of central tendency to describe the 
population and the responses to attitude, knowledge, beliefs, and behaviors of the 
diagnostic tool (See Table below) The analysis plan included an inferential statistical plan 
with the bivariate analysis and multiple logistic regression for the multivariate analysis 
and predictor modeling. (See Table 1 below) The results were interpreted with 
confidence intervals as confidence intervals are important when analyzing the results of 
statistical analysis to help interpret the P-values obtained. 
Data Analysis Matrix 
Table 1 shows a summary of the overall data analysis plan for the study. Please 
see Appendix B for the Mock Tables used in the data analysis. The three specific 
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Threats to Validity 
The threats are relevant to my proposed study because of my quantitative study 
design in which a survey was used to collect data. In the design of my study, the threats 
to external validity consist of population and ecological validity, while the internal threats 
consist of statistical regression and selection. The reasons these are external threats is 
population validity is this type of external validity that can create assumptions regarding 
extrapolation of the entire population as a whole. The internal threats of statistical 
regression because the scores of individuals may be extremely high or low, and selection 
can be an internal threat based on the comparability before the study. 
Ethical Procedures 
Ensuring that participants can refuse to participate without repercussions is an 
ethical guarantee that was included in this study.  Although this study was confidential, it 
was not fully anonymous since the participants could be traced through their IP address. 
The treatment of the data was kept confidential and only used solely for the purpose of 
the study. Protection of the data collected and implementing storage practices to ensure 
privacy were applied.  Strict care was taken to avoid breaches of confidentiality in which 
information is provided to others. I submitted an application to the IRB for permission to 
collect data for the pilot and main study and was granted permission (IRB: 01-21-20-
0311462). I stored the data in my office in a locked cabinet in a file folder for the 





The methodology used was a quantitative correlational study.  Data was collected 
by electronic survey using the survey monkey software.  Data was be kept confidential 
and used solely for the purpose of the study. Protection of the data collected and 
implementing storage practices was applied and enforced for the participants not to 
discuss the survey outside of the research context. In Chapter 4, I present my research 





Chapter 4: Results  
The purpose of this quantitative correlational study was to examine the 
relationship between the independent variables gender, McDonald MS guidelines 
knowledge, and years in practice, and the dependent variable of intent to use guidelines 
among practicing physicians in Missouri, Kansas, Oklahoma, Iowa, Illinois, and 
Nebraska. I examined the association among gender, knowledge, and years in practice 
and intent to use the guidelines. The RQs and accompanying null and alternative 
hypothesis for this study are: 
RQ1: What is the association between gender and the intent to use the guidelines? 
Null Hypothesis: There is no association between gender and intent to use the guidelines.  
Alternative Hypothesis: There is an association between gender and intent to use 
the guidelines.  
RQ2: Research question: What is the association between guidelines knowledge 
and intent to use the guidelines? 
Null hypothesis: There is no association between guidelines knowledge and intent 
to use the guidelines.  
Alternative Hypothesis: There is an association between guidelines knowledge 
and intent to use the guidelines.  
RQ3: Research question: What is the association between years in practice and 
intent to use the MS guidelines? 
Null Hypothesis: There is no association between years in practice and intent to 




Alternative Hypothesis: There is an association between years in practice and 
intent to use the guidelines.  
RQ4: To what extent do gender, guideline knowledge, and years in practice 
predict intent to use the guidelines? 
Null hypothesis: Gender, guideline knowledge, and years in practice do not 
predict intent to use the guidelines 
Alternative Hypothesis: Gender, guidelines knowledge, and years in practice do 
predict intent to use the guidelines. 
Chapter 4 includes a description of a pilot study conducted, data collection, 
reporting of findings from descriptive statistics and inferential analysis of the data, and a 
summary. 
Pilot Study 
I recruited three physicians similar to the physicians in my main study in order to 
test my sampling strategy, the ease and logic of taking the survey on Survey Monkey, and 
completeness and clarity of my survey data collection instrument. Data from the pilot 
study participants was not included in the main study. There were no results from the 
pilot study as the purpose was get the administrative protocol established.  I first received 
approval from the IRB before conducting the pilot study.  There were no changes needed 
to my data collection protocol, the survey content, or the participant recruitment 
strategies. Permission was then obtained from my committee and the IRB to proceed to 






Data were collected in writing via an electronic survey accessed confidentially by 
participants online using Survey Monkey. The survey had five parts: the screening tool 
for eligibility, the informed consent form, the demographic data form, the main survey 
questions, and closing paragraph and form. The sampling frame included all the 
neurologists and primary care physicians who treat MS with an M.D. or D.O. degree and 
license to practice medicine in Missouri, Kansas, Oklahoma, Iowa, Illinois, and 
Nebraska. Data were collected from April 2020 to July 2020. A total of 161 participants 
completed the survey, though the original goal was to recruit 500 participants. Despite 
several attempts to increase the response rate with multiple email reminders no additional 
participants were recruited. Participants provided demographic information that included 
gender, race, McDonald MS guidelines knowledge and years in practice. Data were 
analyzed using version SPSS 27. 
Descriptive Statistics 
The study sample included 75 males (46.60%) and 86 females (53.40%).  Most 
were not Hispanic or Latino (n=141, 87.00%). The average years in practice was 11.18 
(M = 11.18; SD= 10.51). There were 21 Hispanic or Latino (13.00%) and 141 not 
Hispanic or Latino (87.00%). One participant was American Indian or Alaska native 
(0.60%), 12 were Asian (7.40%), 13 were Black or African American (8.00%), 4 were 
Native Hawaiian or another Pacific Islander (2.50%), and 132 were White race (81.50%). 




were very likely to use guidelines (9.30%), whereas 68 were very unlikely to use 
guidelines (42.00%).  
Table 2 
 
Descriptive Characteristics of Study Sample 
Variable N %  
Gender   
Male 75 46.60 
Female 86 53.40 
Ethnicity   
Hispanic or Latino 20 13.00 
Not Hispanic or Latino 141 87.00 
Race   
American Indian or Alaska Native 1 0.60 
Asian 11 7.40 
Black or African American 13 8.00 
Native Hawaiin or Pacific Islander 4 2.50 
White 132 81.50 








Participants Who Stated Intent to Use Guidelines 
Intent to use guidelines Yes (Number)% No (Number)% Total (Number)% 
Yes 42(26.6) % 119(42) % 161(100) % 
No 119(42) % 42(26.6) % 161(100) % 





Yes (Number)% No (Number)% Total (Number)% 
Private practice 0(0) % 161(100) % 161(100) % 
Hospital 161(100) % 0(100) % 161(100) % 





Data were coded as gender 0 = female, and 1 = male, guideline knowledge given 
for 0=fail and 1 = pass, years in practice was discreet, and intent to use 0 = no intent, and 
1 = intent to use.  
Bivariate Logistic Regression Analysis 
A logistic regression analysis was conducted to assess the association between the 
predictor variable, gender, and the outcome, the likelihood of stated, intent to use the 
McDonald guidelines. (see Table 5). The null hypothesis tested for the adjusted OR is the 
probability of being in the target group is equal to the probability of not being in the 
target group (OR=1). The adjusted OR (.674) is less than 1.0, indicated a negative 
association between gender and stated intent to use the McDonald guidelines. The P 
value of the Adjusted OR is .322 and substantially greater than Alpha threshold of (.05) 
and therefore not statistically significant. The Confidence Interval for the Adjusted OR 
(lower: = 308; upper: =1.473) crosses 1.0 and is not statistically significant. Therefore, 









Bivariate Analysis: Gender 
  




95% C.I. for 
EXP(B) 
Upper 
Step 1a Gender (1) -.395 .399 .979 1 .322 .674 .308 1.473 
Constant -.298 .275 1.176 1 .278 .742   
 
A logistic regression analysis was conducted to assess the association between the 
predictor variable, knowledge, and the outcome, the likelihood of stated, intent to use the 
McDonald guidelines. (see table 6) The null hypothesis tested for the adjusted OR is the 
probability of being in the target group is equal to the probability of not being the target 
group (OR = 1). The adjusted OR (1.065) is greater than 1.0, indicated a positive 
association between gender and stated intent to use the McDonald guidelines. The p value 
of the adjusted OR is .873 and substantially greater than Alpha threshold of (.05) and 
therefore not statistically significant. The Confidence Interval for the adjusted OR 
(lower=:.493; upper=:2.300) crosses 1.0 and is not statistically significant. Therefore, the 




Binary Logistic Regression: Knowledge and Years in Practice 
   











Step 1a Knowledge(1) .063 .393 .025 1 .873 1.065 .493 2.300 
Constant -.486 .259 3.502 1 .061 .615   
 
A logistic regression analysis was conducted to assess the association between the 
predictor variable, years in practice, and the outcome, the likelihood of stated, intent to 
use the McDonald guidelines. (see Table 7) The null hypothesis tested for the OR is the 
probability of being in the target group is equal to the probability of not being in the 
target group (OR=1). The OR (1.016) is greater than 1.0, indicated a positive association 
between years in practice and stated intent to use the McDonald guidelines. The p value 
of the OR is .379 and substantially greater than Alpha threshold of (.05) and therefore not 
statistically significant. The Confidence Interval for the OR (lower: =.981; upper: 
=1.051) crosses 1.0 and is not statistically significant. Therefore, the null hypothesis is 




Binary Logistic Regression: Years in Practice 
   






Step 1a Years in Practice .015 .018 .775 1 .379 1.016 .981 1.051 
Constant -.627 .275 5.188 1 .023 .534   
 
Multivariate Analysis 
A multivariate regression analysis was conducted to assess the relationship and 
predictive value of the independent variables, gender, McDonald MS guideline 




The sample included in the analysis was 106 instead of 161 due to the recoding of the 
dependent variable to make it dichotomous to conduct the multivariate binary logistic 
regression. The logistic regression equation is log(p/1-p) = 0.384*gender + 
0.214*guideline knowledge + 0.015*years in practice.  
The first step was to conduct a test multicollinearity test with the following 
results. Results indicated no collinearity with a variance inflation factor of 1.0 for gender, 
and 1.1 for knowledge and 1.1 years in practice.  
The next step in the analysis was to conduct and examine a null regression model 
where no independent variables were included in the analysis.  The classification 
accuracy for Block 0 (62%; p=.013) indicated a modest level of classification accuracy. 
The interpretation of the results is that p = .013, therefore it is significant, and = .612 is 
the odds ratio and that it is not significant. (see Table 8) The interpretation of the 
confidence interval is that it is not statistically significant.  
Table 8 
 
Multivariate Analysis for Intent to Use Guidelines  
 B S.E. Wald df Sig. Exp(B) 
Step 0 Constant -.491 .198 6.135 1 .013 .612 
 
Multiple Logistic Regression Model 
The final step was to test the regression model that included all independent 
variables and the dependent variable. The omnibus test of coefficients model included the 
independent variables as well as the dependent variables and tests the predictive capacity 




of the baseline model and new model, with a chi-square of 2.044, df=3, and sig.=.563. 
The predictive value of the regression model is not very high. The Nagelkerke R square 
value (.026) indicates the amount of variation accounted for in the dependent variable, 
indicating a small variation. The Hosmer and Lemeshow test for goodness of fit for 
logistical regression models. predictive value of the regression model is not very high. 
The result here (Chi-square = 5.529 Sig = .700) is non-significant. The null hypothesis is 
rejected. The contingency (Table 9) indicates substantial differences between expected 
versus observed values for most of the deciles, indicating the weakness of the model. 
Table 9 
 
Contingency Table for Hosmer and Lemeshow Test 







Observed Expected Observed Expected 
Step 1 1 5 5.836 4 3.164 9 
2 7 9.028 7 4.972 14 
3 6 5.743 3 3.257 9 
4 7 9.513 8 5.487 15 
5 7 6.882 4 4.118 11 
6 3 3.099 2 1.901 5 
7 10 8.009 3 4.991 13 
8 9 6.711 2 4.289 11 
9 9 7.015 3 4.985 12 
10 5 6.164 7 5.836 12 
 
The classification accuracy for Block 1 is indicated by 61.3% as the overall 
percentage correct that was predicted regarding intent to use the guidelines. The 
regression model classification accuracy was not an improvement over the null model, in 




The variable in equation is provided in table 9. The Wald statistic show that the 
model is not significant as it does not add anything to the model. The Exp (B) are values 
for the regression equation predicting the dependent variable from the independent 
variable. The Exp (B), the odds ratio was not statistically significant.  
Table 10 
 
Variables in the Equation 





 B SE Wald df Sig. Exp(B) 
Step 1
a 
Gender (1) .384 .408 .886 1 .347 1.468 .660 3.266 
Knowledgeable (1) .214 .408 .275 1 .600 1.239 .557 2.758 
Years in Practice .015 .018 .697 1 .404 1.015 .980 1.051 
Constant -.947 .392 5.825 1 .016 .388   
 
Summary 
It was hypothesized that gender, knowledge of the new treatment guidelines, and 
years in medical practice (independent variables) would predict intent to use the 
McDonald MS guidelines (dependent variable) among physicians who treat multiple 
sclerosis. A correlational analysis was conducted to assess the linear relationship between 
all the variables of interest. There were positive but non-significant relationships between 
the variables. A test for collinearity revealed the near absence for collinearity for each 
independent variable (Gender 1.0 and 1.1 for knowledge 1.0 for years in practice). 
Bivariate regression analysis for each independent variable and the dependent variable 
indicated no statistically significant predictive power for each independent variable and 




outcome according to the analysis. (p = .563) Chapter 5 includes the interpretation of the 






Chapter 5: Discussion, Conclusions, and Recommendations 
The purpose of this quantitative correlational study was to examine the 
relationship between gender, McDonald MS guideline knowledge, and years in practice, 
and intent to use the guidelines. The guidelines improve both the quality of care and 
patient outcomes when correctly used by physicians and a adherence to the McDonald 
clinical guidelines helps clinicians make appropriate clinical diagnosis and treatment 
plans for MS patients. A test for collinearity revealed the near absence of collinearity for 
each independent variable, with variance inflation factors of 1.0 for gender, 1.1 for 
knowledge and 1.1 for years in practice. Bivariate regression analysis for each 
independent variable and the dependent variable indicated no statistically significant 
predictive correlation between each independent variable and the outcome. Lastly, the 
regression omnibus model had a poor predictive capacity for the outcome. (Exp 
(B)=.612; p = .563)  
Interpretation of the Results 
Test for Collinearity 
The test for collinearity revealed the near absence of collinearity for each 
independent variable with variance inflation factors of 1.0 for gender, and 1.1 for 
knowledge and 1.1 for years in practice. Little or no collinearity allows the model a better 
change to detect of each independent variable on the outcome if there is one. Yet, in this 
study even with no collinearity my model was not a good model. This finding of non-
significant relationships between other variables did not support my hypothesis based on 





Bivariate regression analysis for each independent variable and the dependent 
variable indicated no statistically significant predictive power for each independent 
variable and the outcome. My findings contradict the studies that have shown gender to 
be a strong predictor or the outcome. For example, Carrol (2017) found that females have 
a greater intent to use medical apps to improve their health compared to their male 
counterparts, and females with higher education were more likely to use medical apps to 
improve their healthcare outcomes. (Carrol, et, al.,) Deshpande (2009) also analyzed 
gender and intent to eat a healthy diet among students, showing that males students 
reported a lower intention to consume a healthy diet than did females (Deshpande, et, al., 
2009). Thus, gender and intent does exist, which contradicts my study findings. 
Multivariate Analysis 
The multivariate analysis for all independent variables combined and the 
dependent variable indicated no statistically significant predictive power for the model. 
My findings contradict previous studies using multivariate analysis that showed gender to 
be a significant predictor. For example, Khatun (2017) showed that intention to use 
mHealth services was high for both genders (Khatun et, al., 2017). Ng-Sueng (2016) also 
analyzed gender as a predictor of the intent to choose a medical specialty like 
obstetrics/gynecology and dermatology over general practice, suggesting that females had 
an intent to choose obstetrics/gynecology, pediatrics, pediatric surgery, dermatology, and 





Fifteen participants were very likely to use guidelines (9.30%), 26 were somewhat 
likely to use guidelines (17.30%). 51 were neutral (31.50%) and 68 were very unlikely to 
use guidelines (42.00%). Therefore, most were unlikely to use the guidelines, which is 
supported in the peer-reviewed literature by Ghezzi (2018), who suggested that the 
guidelines are not set rules, but rather only serve as a clinical guide for decision making 
(Ghezzi, et, al., 2018). This means that some physicians do not see the importance and 
will not follow suggestions.  
Additional significant information regarding the survey is knowledge of the 
guidelines. The majority were familiar with the guidelines, yet most said they were 
unlikely to use them. Previous research has also shown that clinicians follow the 
guidelines, and they agree that outcomes are improved, but they are not using them 
because even though guidelines are clear and relevant, often they can still derail quality 
improvement efforts. (Nelson, 2016). Further research has indicated that there was a lack 
of agreement with the recommendations with a lack of evidence and environmental 
factors (Luggenberg et, al., 2009). In my study the results showed that guideline 
knowledge did not predict outcome.  
Limitations of the Study 
A key limitation is the small sample size (N = 161), which limits the power of the 
analysis to detect an effect if there is one. This lessened the likelihood to find a 
significant result and decreased the external validity, and the ability to generalize the 




was convenience, non-random sampling and affected the external validity of the findings 
because the population did not have an equal chance of being selected.  
Recommendations 
Recommendations for further studies include studies with a larger sample size to 
include more clinicians’ from around the country. This will increase the power of the 
study to detect an effect if one exists. Additional recommendations for developing a 
survey and questionnaire in the future include adding more questions to the survey to 
capture a larger amount of data. This additional information would include institutional 
policies that clinicians’ have abide by along with added survey questions to test 
clinicians’ awareness of educational tools they have access to in order to educate them 
around their intent to use the guidelines.  
Implications 
The goal of this study was to examine physician characteristics that might be 
associated with intent to use the McDonald MS guidelines. Knowing which factors are 
associated with intent to use could help develop interventions to encourage their use. 
Widespread and consistent intent to use guidelines could change how clinicians’ 
approach MS and provide them with the tools and knowledge to make more informed 
diagnostic and treatment decisions to improve outcomes. MS significantly affects quality 
of life (Rezapour et, al., 2017), which is important consideration in policy-making 





MS is a growing global public health concern. (World Health Organization, 
2016). As MS becomes more prevalent, it is more important to continue to follow the 
McDonald MS guidelines to ensure adequate diagnosis and further treatment for MS 
patients.  Although this study did not confirm if there are physician characteristics factors 
that might predict intent to use the guidelines, it is worth replicating the study with a 
larger sample size to increase the power of the study. Increasing the physician’s 
perceptions and intent to use guidelines for diagnosing MS may allow for continued 
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Appendix A: Survey Questions 
A. PART 2: Demographic Information: 
1. How old were you on your last birthday? (Please fill in a number) 
________________ 
 




D. Prefer not to answer 
 
3. What is your ethnicity? (Instructions-Choose the best answer) 
A. Hispanic or Latino 
B. Not Hispanic or Latino 
 
 
4. What is your race? (Instructions-Choose the best answer) 
A. American Indian or Alaska Native 
B. Asian 
C. Black or African American 
D. Native Hawaiian or other Pacific Islander 
E. White 
    
 
5. How many years have you been in practice? (Please fill in a number) 
________________      
 
6. What is your intent to use the guidelines for biomarkers in the 
diagnoses of MS? (Instructions: Choose the best answer) 
A. Very Likely 
B. Somewhat likely 
C. Neutral 
D. Very unlikely 
 
 





7. The McDonald diagnostic criteria were established in 1997? 




8. The McDonald diagnostic criteria were revised to clarify the 
meanings of attack, dissemination and positive MRI? (Instructions-




9. There have been recent advances in the McDonald Diagnostic 




10. According to Clinical Guidelines it is important to diagnose MS on 





11. According to Guidelines clinicians should counsel people with newly 
diagnosed MS about specific treatment options? (Instructions-




12. Specific criteria for diagnosing PPMS have not changed? 




13. According to the Guidelines there are recommendations to use the 
presence of oligoclonal bands in CSF to make the diagnoses of MS? 







14. What is your intent to use the guidelines for biomarkers in the 
diagnoses of MS? (Instructions: Choose the best answer) 
E. Very Likely 
F. Somewhat likely 
G. Neutral 
H. Very unlikely 
 
15. According to the Guidelines both symptomatic and asymptomatic 
MRI lesions can be considered in determining DIT (dissemination in 





16. According to the Guidelines rapidly evolving severe RRMS is only 







Appendix B: Mock Tables  
Table B1 
 
Distribution of Gender of Study Participants (N = x) 
Gender Yes (Number)% No (Number)% Total (Number)% 
Male (  ) % (  ) % (  ) % 
Female (  ) % (  ) % (  ) % 




Geographic Distribution of Participants (N = x) 
Geographic 
distribution 
Yes (Number)% No (Number)% Total (Number)% 
Private practice (  ) % (  ) % (  ) % 
Hospital ( )% (  ) % (  ) % 




Number and Percent of Participants Who Stated Intent to Use Guidelines (N = x) 
Intent to use 
guidelines 
Yes (Number)% No (Number)% Total (Number)% 
Yes (  ) % (  ) % (  ) % 
No (  ) % (  ) % (  ) % 












Gender Intent to Use 
Guidelines 
      
Guidelines 
Knowledge 
Intent to Use 
Guidelines 
      
Years in Practice Intent to Use 
Guidelines 







Output for Multiple Logistic Regression Analysis  
Outcome:  




Chi Square P Value Odds Ratio  Confidence 
Interval 
(95% CL) 
Intercept      
      
 
 
 
